肺癌救星-易瑞沙(吉非替尼)疗效及复查时间(Lung cancer Savior - Iressa (gefitinib) effect and review time).docVIP

  • 5
  • 0
  • 约6.5千字
  • 约 5页
  • 2018-05-30 发布于河南
  • 举报

肺癌救星-易瑞沙(吉非替尼)疗效及复查时间(Lung cancer Savior - Iressa (gefitinib) effect and review time).doc

肺癌救星-易瑞沙(吉非替尼)疗效及复查时间(Lung cancer Savior - Iressa (gefitinib) effect and review time)

肺癌救星-易瑞沙(吉非替尼)疗效及复查时间(Lung cancer Savior - Iressa (gefitinib) effect and review time) Drug Iressa (Iressa) the emergence of the lung cancer patients suffering from chemotherapy, clinical studies prove the efficacy of Iressa in patients with lung cancer is very significant. Iressa is developed by an international research team, taking a daily Iressa lung cancer patients, the patients received chemotherapy and prolonging the life time is the same. This is the first oral biological agent in the study of lung cancer, said Dr. Edward Kim of the University of Texas Anderson Cancer Research Center at the University of Texas in the United states. Dr. King, along with his team, tested 1466 lung cancer patients in 24 countries worldwide. These patients after the first stage of chemotherapy, half taking Iressa as second course of treatment, the other half in accordance with traditional therapy received docetaxel (a chemotherapy agent) treatment. Results showed that the average life span of two patients was 8 months at the same time. Dr Michael Cullen, of the University of Birmingham, said that Yi Ray Chebbis traditional chemotherapy had less side effects, less harm to patients and easier access to drugs. There will be a lot of lung cancer patients in favor of iressa. Every year, 1 million 200 thousand people die of lung cancer worldwide, and some drugs for lung cancer gradually fail and fail to save their lives. At present, Iressa still needs more testing, because not all are suitable for lung cancer patients taking iressa. The test shows that non-smokers, Asians and female lung cancer patients, more suitable for taking iressa. Then, Iressa (gefitinib) effect which features? 1., better efficacy Targeted therapy can significantly alleviate the clinical symptoms of tumor patients and prolong the survival time for patients with advanced non-small cell lung cancer. At the same time, compared with traditional chemotherapy, targeted therapy is better tolerated, safer and more qualit

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档